Abiopharma

Waiver: Application for Extension of Time to Hold Annual General Meeting

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Change in Interest of Chief Executive Officer, Mr Nicholas Chua

Shareholders who lost money in shares of Alarum Technologies Ltd. (NASDAQ: ALAR) should contact Wolf Haldenstein Immediately

Volition Demonstrates Utility of Rapid, Point-of-Care Finger-Prick Test in Sepsis Patients

Autonomix Medical Completes Good Laboratory Practice (GLP) Preclinical Study, Marking Key Step Toward FDA Submission

AGCO Honors Kyle Hildebrand as 2025 North American Technician of the Year

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Change in interest of Director - Ow Chio Kiat

Cadeler Installs Final Turbine at He Dreiht Offshore Wind Farm

Clinical trial NCT02960022: status: RECRUITING → ACTIVE_NOT_RECRUITING.

Clinical trial NCT06797336: enrollment: 115 → 240 participants.